Atea Pharmaceuticals (AVIR) Receivables - Other (2020)

Atea Pharmaceuticals' Receivables - Other history runs 1 years deep, the most recent figure standing at $5.8 million for Q4 2020.

• In Q4 2020, Receivables - Other changed N/A year-over-year to $5.8 million; the TTM figure through Dec 2020 stood at $5.8 million (changed N/A YoY), while the FY2020 annual figure was $5.8 million, changed N/A from the prior year.
• Receivables - Other for Q4 2020 stood at $5.8 million.
• The five-year high for Receivables - Other was $5.8 million in Q4 2020, with the low at $5.8 million in Q4 2020.